You are here: Industry Insights > Pfizer

News List

Pfizer hits out at other companies over use of firstwordpharma
August 31, 2018
Pfizer recently submitted a citizen petition calling on the FDA to issue guidance that will ensure companies use "truthful and non-misleading" communications regarding the safety and effectiveness of biosimilars compared to the originator products.
Pfizer’s tafamidis reduces risk of death by 30 %, reveals study expressbpd
August 29, 2018
Pfizer has anounced that the recent study has revealed, tafamidis drug reduced the risk of death for patients with a rare and fatal heart disease by around 30 per cent, boosting the prospects of what could be a billion-dollar-a-year drug.
Pfizer eyes ATTR cardiomyopathy filing for tafamidis after acing phase 3 trial fiercebiotech
August 28, 2018
Analysts suggest the drug could reach the market in 2019
Pfizer, Astellas Amend Research Protocols for Two Enzalutamide Trials americanpharmaceuticalreview
August 24, 2018
Pfizer and Astellas announced amendments to the protocols for two registrational Phase 3 trials, ARCHES and EMBARK, designed to evaluate the safety and efficacy of Xtandi (enzalutamide) in men with hormone-sensitive prostate cancer (HSPC).
EpiPen partners Mylan, Pfizer have to fight class action over 'egregious' antitrust claims fiercepharma
August 23, 2018
Mylan's EpiPen was at the center of a price hike scandal that started in 2016. (Greg Friese/Flickr)
Pfizer sales representatives to co-promote Exact Sciences’ Cologuard test in multimillion-dollar deal fiercebiotech
August 23, 2018
Pfizer signed a three-year agreement to co-promote Exact Sciences’ Cologuard stool DNA screening test for colorectal cancer, committing to spend a total of about $70 million on marketing expenses through December 2021.
Pfizer Signs $425m Flu Vaccine Deal with BioNTech contractpharma
August 21, 2018
BioNTech AG, a biotech focused on precise immunotherapies for the treatment of cancer and infectious disease, has entered into a multi-year R&D collaboration with Pfizer to develop mRNA-based vaccines for prevention of influenza (flu).
ESC 2018 preview – Getting to the heart of Pfizer’s amyloidosis data evaluate
August 21, 2018
The most eagerly awaited data from this year’s European Society of Cardiology congress will involve Pfizer’s tafamidis, which has already scored a win in the Attr-act trial in cardiac amyloidosis. The questions now are around the size of the drug’s benefi
Bristol-Myers Squibb - Pfizer Alliance ACROPOLIS™ real-world data program grows to sample size of nearly one million lives worldwide worldpharmanews
August 21, 2018
The Bristol-Myers Squibb-Pfizer Alliance will present 15 Eliquis® (apixaban) posters at the ESC Congress 2018 held in Munich, Germany, August 25-29, 2018. Nine of the posters to be presented are new analyses from the global real-world data (RWD) program..
Pfizer responds to FDA, EMA and Canada after reinspections of plant that makes injected painkillers fiercepharma
August 21, 2018
Pfizer says it has made significant strides in upgrading the sterile injectables plant where it manufactures many of its generic painkillers but acknowledges more must be done after reinspections by the FDA and other regulators.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page